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Abstract: In this study, calcium phosphate nanoparticles with two phases, fluorapatite 
(FA; Ca10(PO4)6F2) and hydroxyapatite (HA; Ca10(PO4)6(OH)2), were prepared using the sol-
gel method. Ethyl phosphate, hydrated calcium nitrate, and ammonium fluoride were used, 
r  espectively, as P, Ca, and F precursors with a Ca:P ratio of 1:72. Powders obtained from 
the sol-gel process were studied after they were dried at 80°C and heat treated at 550°C. The 
degree of crystallinity, particle and crystallite size, powder morphology, chemical structure, 
and phase analysis were investigated by scanning electron microscopy (SEM), X-ray diffraction 
(XRD), Fourier transform infrared spectroscopy (FTIR), and Zetasizer experiments. The results 
of XRD analysis and FTIR showed the presence of hydroxyapatite and fluorapatite phases. 
The sizes of the crystallites estimated from XRD patterns using the Scherrer equation and the 
crystallinity of the hydroxyapatite phase were about 20 nm and 70%, respectively. T  ransmission 
electron microscope and SEM images and Zetasizer experiments showed an average size of 
100 nm. The in vitro behavior of powder was investigated with mouse fibroblast cells. The results 
of these experiments indicated that the powders were biocompatibile and would not cause toxic 
reactions. These compounds could be applied for hard-tissue engineering.
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Introduction
Hydroxyapatite (HA; Ca10(PO4)6(OH)2) is a type of calcium phosphate that has extensive 
application in the healing of bones and teeth, due to its biocompatibility and similar 
composition to that of natural bone.1–5
One of the most common methods for the synthesis of hydroxyapatite and fluorapa-
tite is the sol-gel method.6 Synthesis of fluorohydroxyapatite powder by this method 
is achieved by mixing the raw materials on a molecular scale. In this study, sol-gel 
processing was used to synthesize the calcium phosphate powders. The a  dvantages 
of the sol-gel method over other methods are precise control of composition, low 
  processing t  emperature, and better homogeneity. The required calcination temperature 
for n  anostructured m  aterials that are obtained from this method is low, which prevents 
phase changes. Other a  dvantages of the sol-gel method in comparison with other   methods 
are high purity, homogeneous composition, and low temperature of synthesis.6,7
Pure fluorapatite (FA; Ca10(PO4)6F2) has more chemical and structural stability than 
hydroxyapatite and forms the outer layer of teeth.8–10 F ions encourage the mineralization 
and formation of calcium phosphate crystals in the bone formation process. The effect 
of fluoride ions on the properties of hydroxyapatite can be explained by the i  nvestigation 
of the solid solution of the two phases of fluorapatite and hydroxyapatite.11,12International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The chemical composition factor used to control the 
bioactivity and feasibility of preparing very fine particles 
increases hope for the production of suitable bioactive 
p  owders for dental tissue applications.
Materials and methods
In order to prepare the solution, triethyl phosphite (TEP) 
(C2H5O)3P (Merck), NH4F (Merck), and Ca(NO3)2.4H2O 
(Merck) in ethanol were used, respectively, as P, F, and 
Ca precursors with a nonstoichiometric Ca:P ratio equal 
to 1:72. First, NH4F was added to TEP in ethanol (P/F = 6) 
and, in a separate container, calcium nitrate tetrahydrate was 
dissolved in ethanol. The resulting solutions were vigorously 
agitated for 24 hours. Subsequently, the solution containing 
Ca was added to the solution containing P. The resulting 
solution was kept at room temperature for 72 hours and 
then aged at room temperature for a period of 24 hours. 
The samples were dried at 70°C for 3 days and heat treated 
at 550°C for 1 hour. The resultant powders were milled using 
alumina haven for 20 minutes. Figure 1 shows the process of 
powder preparation. Chemical properties, phase composition, 
chemical structure and size, and morphological properties 
of the particles were studied by X-ray diffraction (XRD) 
(Siemens and Bruker, Erlangen, Germany), Fourier transform 
infrared spectroscopy (FTIR) (BoMem Model MB100), 
Zetasizer (3000 HAS; Malvern Instruments Ltd, Malvern, 
UK), scanning electron microscopy (SEM) (XL30; Philips, 
Eindhoven, Holland), and transmission electron microscopy 
(TEM) (CM200FEG; Philips).
For cytotoxicity analysis, fibroblast cell suspension (L929) 
from mouse tails was prepared according to International 
  Organization for Standardization 10993 standards. The 
  control powders (TCPS) were well cleaned and sterilized by 
the autoclave method. Individual samples were placed in Petri 
dishes using a sterilized pincer; 3 cc of the cell suspension was 
removed by pipette and poured into the control and experimental 
samples. Thereafter, all of the samples were placed separately in 
a   Memmert incubator at 37°C for 24 and 48 hours. The samples 
in the polystyrene Petri dish were removed from the incubator 
after 24 and 48 hours and studied using an Eclipse TS-100 
photonic microscope (200X; Nikon, Tokyo, Japan).
Results and discussion
FTIr analysis
Figure 2 shows the bands or functional groups of the 
p  owders. The apatite structure indicates 560–1610 cm-1 and 
1000–1100 cm-1 vibration modes for the PO group. A broad 
peak indicates 2600–3800 cm-1 related to the OH group. A small 
peak between 3536 cm-1 and 3545 cm-1 relates to the OHF 
bond, which indicates F ion penetration into the apatite network. 
The peak 1635 cm-1 relates to the water-bending mode.13
Suchanek et al showed an OH vibration mode of about 
630 cm-1 for hydroxyapatite.14 This peak is not shown in 
F  igure 2. A small peak in the range 3200–3400 cm-1 relates 
to the water in the structure. A 3541 cm-1 stretching mode was 
observed related to the hydroxyl groups. The presence of 
the hydroxyl group was due to the hydrogen bond of the 
fluorine ions. This peak confirmed the crystal structure of 
the flourapatite with hydroxyl groups. These observations 
for fluorohydroxyapatite powder are due to the hydrogen 
bond formation between F and OH (FOH), which indicates 
substitution F ions instead of OH ions in the apatite structure. 
However, the exact amount of F ions replaced with OH ions 
could not be determined by FTIR analysis. Substitution of 
different ions in the apatite structure reduces the symmetry 
and thus causes band absorption in the IR spectrum. A sharp 
and broad peak between 900 cm-1 and 1100 cm-1 is related 
to the PO4
3- group. Stretching and bending modes for PO4
3- 
are showed at 600 cm-1, 572–560 cm-1, and 561 cm-1. The 
band of 1956 cm-1 is related to the PO4
3- group with fluo-
rapatite and hydroxyapatite. The band of 956 cm-1 is related 
to PO4
3- group with flourapatite and flourohydroxyapatite. 
Bands of 963 cm-1 and 1500–1400 cm-1 are related to the CO 
group, which is related to the carbonate ion of hydroxyapatite 
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powder. Van der Houwen et al also present carbonate ions in 
a band of 873–1456 cm-1 related to dissolving CO2.15
XrD analysis
The XRD pattern of heat-treated powder at 550°C is shown 
in Figure 3. Peaks related to hydroxyapatite are indicated in 
the range of 2θ = 25–35. Based on this spectrum, two-phase 
hydroxyapatite and fluorapatite are presented in the sample.
Based on XRD, the presence of a tetra calcium 
p  hosphate phase is not observed. The value of this phase 
in the t  hermodynamic conditions for the mixing ratio 
Ca:P = 1:72 is theoretically about 40%. A change in the 
chemical ratio of the sol-gel process with different com-
binations of calcium phosphate led to the predicted phase 
based on equilibrium curves, which are not the same as 
other researchers have found.16 Particle size is detected by 
the Scherer equation:13
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Figure 2 Fourier transform infrared spectroscopy of the heat-treated powder at 550°c.
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In Equation 1, D is particle size (A°), K is 0.9, λ is the 
wavelength of X-rays against 1.54056 A°, λ is Bragg angle 
of peak from diffraction, and B1/2 is in terms of radians.
 
BB b ms 1
2
22 =- ()   (2)
Based on Equation 1, two (Scherer) particles of about 
20 nm were obtained. Crystallinity degree of samples was 
calculated from Equation 3:13
 
XV I c =- - () 1 112300 300 /   (3)
Crystallinity degree of samples obtained was about 70%.
Microscopic analysis
SEM images of powders with different magnifications 
(4000X and 10,000X) are shown in Figure 5. Spherical 
  particles formed in this temperature showed particle sizes to be 
about 100 nm and very homogeneous. Considering the SEM 
image, it seems that the agglomerates were sufficiently d  ispersed 
in the Zetasizer testing conditions. The Zetasizer experiments 
for the dispersed particles in its own conditions showed particle 
sizes with an average size of 100 nm (Figure 4).
Electron transmission microscopy images and d  iffraction 
patterns of powder samples are shown in Figure 6. TEM 
images show particle size to be about 100 nm, which 
  conforms to Zetasizer patterns.
cellular analysis
For cytotoxicity investigations, cells cultured in the presence 
of samples were observed after 72 hours under an inverted 
A
B
Figure  5  Scanning  electron  microscopy  images  of  fluorapatite–hydroxyapatite 
nanoparticles (5A: 4000X; 5B:10,000X).
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Figure 4 Particle size distribution of two-phase fluorapatite–hydroxyapatite powder 
at 550°c. Figure 6 Transmission electron microscopy shows nanoparticles with regular shapes.
microscope (Nikon TS-100 Model 200X). Figure 7 shows 
cell growth on the control (TCPS) surface and nanopowders. 
Figure 7A shows the growth of the fibroblast cells on the 
control Petri dish with good cellular growth and adhesion at 
37°C. Figure 7B shows cellular growth with nanopowders. 
The nanopowder sample has good growth that is almost 
comparable with the control sample.International Journal of Nanomedicine
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Conclusion
In this study, the powder sample of the fluorapatite– 
hydroxyapatite nanocomposite was synthesized with a Ca:P 
ratio of 1:72.
FTIR analysis revealed that the nanocomposite was slightly 
carbonated. The crystallinity of the   hydroxyapatite component 
estimated by XRD was found to be about 70%. Very fine distri-
bution of the nanosized fluorapatite–  hydroxyapatite grains, as 
well as the calcium-deficient hydroxyapatite agglomerates, was 
identified in the SEM s  tudies. XRD-based estimation revealed 
the crystallite sizes to be about 20 nm. The Zetasizer experi-
ments for the d  ispersed particles in its own conditions showed an 
average size of 100 nm. SEM and TEM analysis showed particle 
size to be about 100 nm, which conforms to   Zetasizer   patterns. 
The results of cellular investigation show the positive effect of 
nanopowders on the cells. Cellular studies show nontoxicity of 
nanoparticles compared with the control sample. These powders 
can be used as a scaffold for bone and teeth.
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Figure 7 Optical microscopic images of cells cultured in the presence of control 
samples (sample (A) containing the powder (B)).